Currently, ophthalmology tops the list of specialties with the most ongoing clinical trials, followed by oncology, family practice, cardiology and gastroenterology. Nine fast facts on ongoing clinical ...

MFDS IND approval enables a multicenter, randomized, double-blind, vehicle-controlled phase 2 study in ~150 DED patients, randomized 1:1:1 to two dosing arms versus control over 12 weeks. Prior phase ...

Please provide your email address to receive an email when new articles are posted on . Clinical trials continue to be a driving force in ophthalmology, propelling the development of innovative ...

In late 2025, a group of researchers that included Maria Emfietzoglou, MD, and Victor S.M.C. Correa, MD, published a paper titled, “Inner Plexiform Layer Substrata Are Discernible with Commercial OCT ...

Joseph M. Coney, MD, FACS, discusses the importance of diverse representation in clinical trials for the ongoing advancement of safe and effective treatments, and underscores the need for cultivating ...

Glaucoma is likely to be treated when IOP reaches 22 mm Hg, but research shows that risk consistently increases even at lower IOP levels, according to a study published in JAMA Ophthalmology.“In ...

For years, the John A. Moran Eye Center’s Clinical Ophthalmology Resource for Education (CORE) has offered worldwide access to high-quality ophthalmic learning—an important step in addressing curable ...

At the Alan S. Crandall Center for Glaucoma Innovation, Director Iqbal Ike K. Ahmed, MD, FRCSC, and Associate Director Ian F. Pitha, MD, PhD, evaluate and advance new approaches to glaucoma care ...

The Department of Ophthalmology and Visual Sciences' 26th Annual Research Symposium will take place on Friday, June 13, 2024, at the Birmingham Botanical Gardens' Garden Center. This full-day event ...